Drug detox for Delray Beach — substance-specific protocols, not one-size-fits-all.

RECO Island is a private, small-census medical detox and residential rehab in Delray Beach — zero miles from Pineapple Grove, Lake Ida, and Tropic Isle. Withdrawal management is physician-led and substance-specific: COWS-guided buprenorphine induction for opioids, slow clonazepam or diazepam tapers for benzodiazepines, and supportive care for stimulant withdrawal. Detox transitions in-house to residential and MAT continuation on the same campus — no waitlists, no third-party handoffs.

RECO Island’s medical detox and residential campus sits in Delray Beach, one block off Atlantic Avenue and a short walk from the ocean. For residents of Pineapple Grove, Lake Ida, Tropic Isle, Osceola Park, and the Beach District, that means physician-led withdrawal management stays inside the neighborhood — and residential treatment begins in-house, without the delay of a third-party detox handoff before the clinical work starts.

Substance-specific withdrawal protocols

Opioid, benzodiazepine, and stimulant withdrawal are clinically distinct syndromes and respond to different management. Opioid withdrawal — from heroin, fentanyl, or prescription opioids — is intensely uncomfortable but rarely medically dangerous in an otherwise healthy adult. COWS scoring guides buprenorphine induction during drug detox: the first dose is typically held until COWS is at least 8-12 to reduce the risk of precipitated withdrawal, then titrated to symptom control over 24-72 hours. Fentanyl-only exposure requires additional care given lipophilic tissue reservoirs; low-dose induction and adjunctive lofexidine or clonidine are sometimes appropriate.

Benzodiazepine withdrawal is clinically closer to alcohol withdrawal than to opioid withdrawal. Autonomic hyperactivity, seizure risk, and delirium require a slow taper — generally converting short-acting agents such as alprazolam or lorazepam to a long half-life agent like clonazepam or diazepam and reducing by roughly ten percent per week. CIWA-Ar (or CIWA-B for benzodiazepine-specific monitoring), phenobarbital adjunct in complicated cases, and inpatient observation through the first 72-96 hours are standard.

Stimulant withdrawal from cocaine and methamphetamine does not require pharmacologic detox in the classical sense but produces a severe crash phase — depression, anhedonia, hypersomnia, and marked craving. PHQ-9 monitoring, supportive care for sleep, and early screening for stimulant-induced psychiatric symptoms including psychotic features that may persist matter clinically. Running one protocol across all substances is bad medicine.

Polysubstance detox and the sequencing decision

Concurrent use of alcohol, benzodiazepines, and opioids is an increasingly common presentation, particularly among clients with prescription-driven trajectories or those exposed to fentanyl-adulterated stimulants. The clinical principle is straightforward: manage life-threatening withdrawal syndromes first. Alcohol and benzodiazepine withdrawal carry seizure and delirium risk and take priority, with CIWA-Ar-guided benzodiazepine loading or phenobarbital protocols.

Opioid MAT is initiated concurrently rather than sequentially. Buprenorphine induction can proceed once the client is in objective opioid withdrawal (COWS ≥ 8-12) and does not have to wait for the benzodiazepine taper to conclude. Stimulant withdrawal is addressed supportively throughout. Every polysubstance detox at RECO Island is individualized based on which substances were used, in what quantities, over what duration, and against what medical comorbidity — and the plan is documented in the admission note before the first dose is administered.

Medical comorbidity is the norm, not the exception

Chronic substance use produces medical comorbidity. Injection use is a vector for hepatitis C, HIV, endocarditis, and soft-tissue infections. Stimulant use accelerates cardiovascular disease and can produce left ventricular hypertrophy on a ten-year timescale. Untreated hypertension, undiagnosed type 2 diabetes, malnutrition, iron-deficiency anemia, and under-treated chronic pain that was being self-medicated are routine findings on admission.

The RECO Island medical evaluation on admission includes vitals, physical examination, comprehensive metabolic panel, complete blood count, liver function tests, hepatitis and HIV screening where indicated, urine toxicology, EKG when clinically appropriate, and psychiatric assessment with PHQ-9 and GAD-7 as baseline instruments. Findings are managed concurrently rather than deferred to outpatient primary care after discharge. For many clients, detox is the first meaningful medical contact in years, and the discharge summary establishes a real primary care baseline that community providers can build on.

The handoff into residential and MAT continuation

Detox produces safe withdrawal. Residential treatment produces early-recovery skill building — CBT and DBT for emotion regulation and craving management, MI for ambivalence, trauma-focused therapy (EMDR, prolonged exposure) when trauma is driving relapse, and ACT for values-based commitment. MAT protects against relapse during the vulnerable first months when relapse rates are highest.

The RECO Island model is to initiate MAT during detox where indicated — buprenorphine for opioid use disorder, extended-release naltrexone for alcohol use disorder or for opioid use disorder after a documented opioid-free window (typically 7-10 days for short-acting opioids) — continue it through residential and PHP/IOP, and hand off to community MAT maintenance at discharge. Detox alone, without residential and without MAT continuation, has a well-documented relapse rate that borders on universal within 90 days for opioid use disorder. The three-part model exists for a reason.

Why the small-census model matters for detox

Detox is not a hotel service. Medication decisions during opioid, benzodiazepine, and polysubstance withdrawal require nursing observation, physician availability, and the ability to adjust protocols in real time — hourly through the first 24-48 hours, and multiple times per day across the acute phase. High-census facilities dilute that attention across too many clients per shift; the order that should have been changed at 2 a.m. gets changed at the morning round.

RECO Island operates as a private, small-census facility. Nurse-to-client ratios are structured for hourly reassessment during the acute withdrawal phase, and the medical director is on call — not rotating across a dozen contracted facilities. There are no waitlists between detox and residential; the transition is in-house, on the same campus, with the same clinical team carrying continuity of care into the residential phase.

What to expect on admission from Delray Beach

Admission begins with a phone call to the admissions team, an insurance verification (typically completed within an hour during business hours), and a brief clinical screen to confirm level of care using ASAM Criteria across all six dimensions — acute intoxication and withdrawal, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse and continued-use potential, and recovery environment. Level of care is a clinical determination, not a marketing one.

On the admission day, clients complete medical and psychiatric evaluation, baseline labs, and a personal-belongings inventory. Withdrawal management begins within hours of admission. Adjunctive medications for symptom relief include ondansetron for nausea, loperamide for opioid-related GI symptoms, clonidine or lofexidine for autonomic hyperactivity, hydroxyzine for anxiety, trazodone or mirtazapine for sleep, and short courses of low-dose quetiapine or olanzapine when severe agitation or stimulant-induced psychiatric symptoms are present. Standing benzodiazepine orders are avoided outside of documented alcohol or benzodiazepine withdrawal protocols.

Insurance and admissions from Delray Beach

RECO Island is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS, and accepts most other commercial PPO plans out-of-network with a benefits verification. Verification is a same-day process during business hours and includes deductible status, out-of-pocket maximum, prior-authorization requirements, and length-of-stay projections for detox and residential.

Because the Delray Beach campus is zero miles from downtown — a short drive from Pineapple Grove, Lake Ida, and Tropic Isle — admissions can typically move from first phone call to in-person medical evaluation on the same day for local clients when the clinical picture supports immediate admission. For clients with co-occurring depression, anxiety, or trauma, psychiatric medication management runs in parallel with detox — sertraline or another SSRI, aripiprazole for augmentation, buspirone for anxiety when benzodiazepines are contraindicated, and prazosin for trauma-related nightmares — under the supervision of an addiction-trained psychiatrist.

Serving residents of: Pineapple Grove, Lake Ida, Tropic Isle, Beach District, Osceola Park.